Evidence map›Paper›PMID 35779040›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2022

A preliminary evaluation of in vivo response to a filament-wound macroporous collagen midurethral sling in an ovine model.

Ahmad O Khalifa, Ilaha Isali, Hakan Celik, Michael Mastran, Phillip McClellan, Callan Gillespie, Subba Shankar, Gregory T MacLennan, James M Anderson, Fredrick R Schumacher and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Ahmad O KhalifaDepartment of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0003-1376-5697
Ilaha IsaliDepartment of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0002-8100-0971
Hakan CelikDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Michael MastranCollaMedix Inc., Cleveland, Ohio, USA.
Phillip McClellanDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Callan GillespieInstitute Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Subba ShankarCollaMedix Inc., Cleveland, Ohio, USA.
Gregory T MacLennanDepartment of Pathology, Case Western Reserve University & University Hospitals Case Medical Center, Cleveland, Ohio, USA.
James M AndersonDepartment of Pathology, Case Western Reserve University & University Hospitals Case Medical Center, Cleveland, Ohio, USA.
Fredrick R SchumacherDepartment of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Ozan AkkusDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Adonis K HijazDepartment of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
University Hospitals of Cleveland · USCase Western Reserve University · USCleveland Medical Devices · USCleveland Clinic · US

Funding

KUH-TN Training CoreTL1DK132770 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI Evi X. Stavrou · 2021 to 2026
$2.5M
Immunoregenerative treatment of Stress Urinary Incontinence by Autologous Macrophage TherapyR21HD095439 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI AKKUS, OZAN, HIJAZ, ADONIS K · 2018 to 2019
$440k
NICHD NIH HHS R21 HD095439NIDDK NIH HHS TL1 DK132770
6 · The paper itself

Abstract

Stress urinary incontinence (SUI) impacts ~1/3 of women over age 50. Negative publicity around PP meshes used in pelvic prolapse repair drives the need for identifying alternative biomaterials for SUI repair. Our study evaluated in vivo response to collagen sling implanted in an ovine model. Electrocompacted collagen threads were filament wound as slings and crosslinked in genipin. Collagen slings were implanted suburethrally mimicking the transvaginal tape technique. Main study groups were: Collagen sling (n = 3, 6 months) and PP sling (n = 3, 6 months). Collagen sling was also tested at 3-weeks (n = 1) to observe early-stage tissue response and 1-year (n = 2) to assess biomaterial longevity in a preliminary capacity. Collagen slings healed to a fibrous ligament texture at 6 months and maintained such texture to 1 year. Histological scoring indicated biocompatible responses to collagen slings with no adverse events. All study groups exhibited complete tissue ingrowth and interstitial de novo collagen deposition at all time points. Collagen threads induced orderly de novo collagen deposition that was aligned along long axes of threads. Tissue infiltrated collagen slings that were explanted at 6 and 12 months presented similar structural strength with native tissues such as vagina and fascia, and PP (Lynx) slings (p > .05). With the limitation of low number of animals per time point in hindsight, this preliminary study justifies evaluation of collagen slings in a larger sample size of animals, particularly to assess persistence of ligamentous tissue response over longer durations than 1-year.

Indexed as

Suburethral SlingsUrinary Incontinence, StressAnimalsBiocompatible MaterialsCollagenFemaleSheepVaginaBiocompatible MaterialsCollagencollagenovine modelslingstress urinary incontinence

Identifiers

PMID35779040
PMCPMC10148708
OpenAlexW4283784422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.